Friday, 18 December 2009
Ipilimumab is a new drug treatment, monotherapy that is being investigated in patients with Advanced melanoma.In a report from the Lancet a phase 2 clinical trial showed that the drug produced a dose dependant effect.Trials are still on going but the reaserch around this cancer is promising.
Posted by Pharmacy Bot at 02:44
Tuesday, 15 December 2009
Medical News website or you can follow it by clicking the story item on the left......
Have a great day, now let me put the kettle ON....
Posted by Pharmacy Bot at 14:43